Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A safety, tolerability, and efficacy study of the investigational VX-264 in participants with Type 1 Diabetes is ongoing in Phase 1/Phase 2 and currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• VX-264

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING